Simbol | YTM % | Volum | Harga % | Kupon % | Tarikh Matang | Jumlah tertunggak | Nilai muka | Jumlah denominasi min | Pengeluar |
---|---|---|---|---|---|---|---|---|---|
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 6.57% | 600 K | 84.44% | 4.55% | 2035-03-15 | 107.646 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 6.56% | 15 K | 79.63% | 4.85% | 2044-06-15 | 65.232 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 6.44% | 10 K | 79.20% | 4.75% | 2045-03-15 | 53.51 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 6.31% | 5 K | 80.72% | 4.63% | 2042-10-01 | 67.493 M USD | 1,000.00 USD | 2,000.00 USD | Actavis, Inc. |
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029 | 5.71% | 50 K | 89.00% | 3.20% | 2029-11-21 | 62.515 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064 | 5.60% | 16.456 M | 98.07% | 5.50% | 2064-03-15 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
4ABBABBVIE 15/45 | 5.54% | 0 | 89.07% | 4.70% | 2045-05-14 | 2.7 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044 | 5.53% | 156 K | 91.37% | 4.85% | 2044-06-15 | 1.008 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048 | 5.50% | 43 K | 90.94% | 4.88% | 2048-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
US287YAW9ABBVIE 16/46 | 5.50% | 0 | 85.80% | 4.45% | 2046-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042 | 5.49% | 570 K | 89.63% | 4.63% | 2042-10-01 | 389.217 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054 | 5.49% | 22.277 M | 98.56% | 5.40% | 2054-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045 | 5.46% | 90 K | 90.75% | 4.75% | 2045-03-15 | 827.091 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044 | 5.45% | 1.34 M | 98.71% | 5.35% | 2044-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049 | 5.40% | 31.367 M | 82.77% | 4.25% | 2049-11-21 | 5.745 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042 | 5.40% | 1.443 M | 87.92% | 4.40% | 2042-11-06 | 2.599 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039 | 5.30% | 4.923 M | 86.54% | 4.05% | 2039-11-21 | 4 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
US287YAV1ABBVIE 16/36 | 5.25% | 0 | 91.57% | 4.30% | 2036-05-14 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
US287YAR0ABBVIE 15/35 | 5.20% | 0 | 94.24% | 4.50% | 2035-05-14 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035 | 5.13% | 488 K | 95.26% | 4.55% | 2035-03-15 | 1.681 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034 | 5.11% | 6.573 M | 99.53% | 5.05% | 2034-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031 | 4.94% | 10.097 M | 100.05% | 4.95% | 2031-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029 | 4.80% | 7.816 M | 92.85% | 3.20% | 2029-11-21 | 5.437 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
AA5QDALLERGAN FNDG 15/25 | 4.76% | 0 | 99.06% | 3.80% | 2025-03-15 | 130.225 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029 | 4.76% | 13.33 M | 100.15% | 4.80% | 2029-03-15 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026 | 4.76% | 0 | 96.53% | 2.95% | 2026-11-21 | 9.245 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
US287YAY5ABBVIE 16/26 | 4.65% | 0 | 97.92% | 3.20% | 2026-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028 | 4.64% | 8.836 M | 98.59% | 4.25% | 2028-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027 | 4.62% | 7.135 M | 100.40% | 4.80% | 2027-03-15 | 2.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026 | 4.56% | 3.663 M | 96.91% | 2.95% | 2026-11-21 | 3.991 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
4ABCABBVIE 15/25 | 4.33% | 0 | 99.29% | 3.60% | 2025-05-14 | 3.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025 | 4.21% | 1.55 M | 99.60% | 3.80% | 2025-03-15 | 2.889 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
XS190919331ALLERGAN FNDG 18/28 | 3.79% | 0 | 95.69% | 2.63% | 2028-11-15 | 72.107 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS |
XXS162262122ALLERGAN FNDG 17/29 | 3.77% | 0 | 93.12% | 2.13% | 2029-06-01 | 36.462 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS |
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049 | 3.07% | 0 | 121.31% | 4.25% | 2049-11-21 | 4.95 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045 | 3.03% | 0 | 126.76% | 4.75% | 2045-03-15 | 5 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044 | 2.96% | 0 | 128.71% | 4.85% | 2044-06-15 | 100 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
4ABGABBVIE 19/31 | 2.89% | 0 | 89.58% | 1.25% | 2031-11-18 | 650 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. |
XS212591491ABBVIE 20/29 | 2.77% | 0 | 97.23% | 2.13% | 2029-06-01 | 506.088 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. |
XS212591483ABBVIE 20/28 | 2.75% | 0 | 99.53% | 2.63% | 2028-11-15 | 427.793 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. |
ABBV5066461AbbVie Inc. 2.6% 21-NOV-2024 | 2.70% | 2.58 M | 99.90% | 2.60% | 2024-11-21 | 3.739 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
XS152090781ABBVIE 16/28 | 2.68% | 0 | 97.89% | 2.13% | 2028-11-17 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. |
4ABEABBVIE 19/27 | 2.52% | 0 | 94.87% | 0.75% | 2027-11-18 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. |
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035 | 2.01% | 0 | 123.74% | 4.55% | 2035-03-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025 | 1.63% | 0 | 102.15% | 3.80% | 2025-03-15 | 1.268 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV4911714AbbVie Inc. 2.6% 21-NOV-2024 | −3.63% | 0 | 106.34% | 2.60% | 2024-11-21 | 10.86 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025 | — | — | — | 3.80% | 2025-03-15 | — | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042 | — | — | — | 4.40% | 2042-11-06 | 1.1 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |